What’s New in the 2020 Update to the CAP/ASCO ER/PgR Testing Guidelines in Breast Cancer?​

At the beginning of 2020, an update to the CAP/ASCO ER/PgR testing guidelines in breast cancer was released. This webinar will review what has changed, what has stayed the same and how these changes might affect ER/PgR testing standard operating procedures, interpretation and reporting in your laboratory. Case-based examples of application of the recommendations will be provided and frequently asked questions about the update will be answered.

Learning Objectives:

1. Identify new aspects of the CAP/ASCO ER/PgR testing in breast cancer guideline updates that affect hormone receptor standard testing operating procedures, interpretation and reporting for invasive breast cancer and ductal carcinoma in situ.
2. Review how to apply the new recommendations in specific ER/PgR testing patient care scenarios.

Webinar Materials:
Handout (PDF)

Presenter:
Kimberly Allison, MD